4-phenylbutyric acid has been researched along with isoproterenol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ayala, P; Copaja, M; Díaz-Araya, G; Humeres, C; Lavandero, S; Letelier, A; Montenegro, J; Pivet, D; Troncoso, R; Urroz, PA; Vicencio, JM; Vivar, R | 1 |
1 review(s) available for 4-phenylbutyric acid and isoproterenol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for 4-phenylbutyric acid and isoproterenol
Article | Year |
---|---|
Attenuation of endoplasmic reticulum stress using the chemical chaperone 4-phenylbutyric acid prevents cardiac fibrosis induced by isoproterenol.
Topics: Adrenergic beta-Agonists; Animals; Endoplasmic Reticulum Stress; Fibrosis; Humans; Isoproterenol; Male; Molecular Chaperones; Myocardium; Myocytes, Cardiac; Phenylbutyrates; Protein Folding; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor CHOP | 2012 |